Brief: Creso Pharma Posts HY Revenue From Ordinary Activities A$4.3 Million

Melodiol Global Health

31/08/2022 09:15

Aug 31 (Reuters) - Creso Pharma Ltd  CPH.AX :
    * HY REVENUE FROM ORDINARY ACTIVITIES A$4.3 MILLION VERSUS
A$3
MILLION
    * HY NET LOSS ATTRIBUTABLE A$7.1 MILLION VERSUS LOSS OF
A$19.0
MILLION

Source text for Eikon:  ID:nASX47C9Jm 
Further company coverage:  CPH.AX 

 ((reuters.briefs@thomsonreuters.com;))